Compound ID | 1825
OPT-200
Class: Lipopolysaccharide synthesis inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Targets synthesis of lipopolysaccharide (LPS) |
| Description: | Synthetic compound |
| Institute where first reported: | Oppilotech |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Preclinical |
| Development status: | Active (as of 2022) |
| External links: | |
| Citation: | https://oppilotech.com/pipeline/ |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.